<DOC>
	<DOCNO>NCT02630069</DOCNO>
	<brief_summary>This study 12-week , randomize , double-blind , placebo-controlled trial cytidine-5'-diphosphate choline amphetamine-type stimulants-using adolescent .</brief_summary>
	<brief_title>CDP-choline Treatment ATS Users</brief_title>
	<detailed_description>This study 12-week , randomize , double-blind , placebo-controlled trial cytidine-5'-diphosphate choline ( CDP-choline ) amphetamine-type stimulants-using adolescent . Multi-level assessment perform determine whether CDP-choline administration cognitive behavioral therapy ( CBT ) , compare placebo administration CBT , 1 ) repair ATS-induced neural cell damage target brain region , 2 ) improve cognitive deficit normalize relevant target neural circuit , 3 ) reduce ATS-taking behavior ATS-using adolescent .</detailed_description>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Amphetamine</mesh_term>
	<mesh_term>Choline</mesh_term>
	<mesh_term>Cytidine Diphosphate Choline</mesh_term>
	<criteria>Aged 1419 year Amphetamine ( amphetaminelike ) use disorder ( DSMIVTR ) Informed consent Seeking treatment Major medical neurological illness Psychiatric illnesses require hospitalization , prescription psychotropic medication , emergency psychiatric intervention Current past diagnosis psychotic disorder , bipolar disorder , conduct disorder , attentiondeficit hyperactivity disorder Occasional ATS use ( less monthly use ) IQ 80 low Pregnancy breastfeed Contraindications MRI scan Clinically significant suicidal homicidal ideation Substance use disorder ( substance amphetamine MA )</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>19 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>amphetamine type stimulant</keyword>
	<keyword>adolescent</keyword>
</DOC>